Conditions

Home / Conditions

 

Provenge Extends Survival of mCRPC Patients By Up to 4 Years, Data Show

Provenge Extends Survival of mCRPC Patients By Up to 4 Years, Data Show

This post was originally published on this site Treatment with the immunotherapy Provenge (sipuleucel-T) in a real-world setting is showing  similar safety and efficacy in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC) as in clinical trials, a study shows. The observational registry study — called PROCEED (NCT01306890) — conducted at urology…

ARPF Set to Host Brain Longevity Therapy Training and Symposium

ARPF Set to Host Brain Longevity Therapy Training and Symposium

This post was originally published on this site With the goal of warding off Alzheimer’s disease through integrative medicine, the Alzheimer’s Research and Prevention Foundation (ARPF) will host its third Brain Longevity Therapy Training and Symposium Oct. 24-27 in Scottsdale, Arizona. The Brain Longevity Specialist certification program, which includes yoga training and other techniques, is a…

Health Canada and European Commission OK Tecentriq-Chemo Combo for Aggressive Lung Cancer

Health Canada and European Commission OK Tecentriq-Chemo Combo for Aggressive Lung Cancer

This post was originally published on this site Health Canada and the European Commission have approved Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin plus etoposide) as a first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC), an aggressive form of lung cancer. Tecentriq is an immune checkpoint inhibitor developed and marketed by Genentech, a Roche…

Biosimilar ABP 798 Shows Similar Safety and Efficacy to Rituxan in Phase 3 Trial for Non-Hodgkin’s Lymphoma

Biosimilar ABP 798 Shows Similar Safety and Efficacy to Rituxan in Phase 3 Trial for Non-Hodgkin’s Lymphoma

This post was originally published on this site ABP 798, a biosimilar to Rituxan (rituximab), is showing comparable efficacy results to its original product in a Phase 3 trial for non-Hodgkin’s lymphoma patients, the treatment’s co-developers, Amgen and Allergan, have announced. The therapy also has a similar safety and immunogenicity (i.e., whether the immune system reacts against…

Cancer by the Numbers

Cancer by the Numbers

This post was originally published on this site 1: Number of times a doctor told me, “Best-case scenario, you’ll be stuck with a ‘frankenboob.’ ” 0: Odds a doctor gave me that I’d be able to get chemo in time to save my life. 3: Months a doctor predicted I’d live. 10: Age of my daughter when…

FDA Grants Orphan Drug Status to BioXcel’s BXCL701 as Potential AML Treatment

FDA Grants Orphan Drug Status to BioXcel’s BXCL701 as Potential AML Treatment

This post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to BXCL701, one of BioXcel Therapeutics’ lead immunotherapies for the treatment of acute myeloid leukemia (AML). Orphan drug status is given to investigative treatments for rare diseases, defined in the U.S. as disorders that affect…

Cancer Patients Around the World to Receive Henry Schein ‘Comfort Kits’

Cancer Patients Around the World to Receive Henry Schein ‘Comfort Kits’

This post was originally published on this site Henry Schein, a foundation devoted to promoting dental and medical health, has produced more than 27,000 comfort kits for people fighting cancer in the U.S. The kits, which are meant to make patients feel at home while receiving care away from home, were assembled by more than 2,100 Team…

Activities Underway to Mark Ovarian Cancer Awareness Month

Activities Underway to Mark Ovarian Cancer Awareness Month

This post was originally published on this site Efforts including financial assistance, fundraising and education are underway to mark Ovarian Cancer Awareness Month. The annual September observance includes specialty lender Fifth Season Financial, which seeks to ease the financial burden of treatment of ovarian cancer, prostate cancer and other advanced-stage disorders. The lender’s Funds for Living…

Largest-ever African American Prostate Cancer Study Seeks Participants

Largest-ever African American Prostate Cancer Study Seeks Participants

This post was originally published on this site African American men recently diagnosed with prostate cancer are being recruited across the U.S. for the largest-ever prostate cancer study in this ethnic group. The study is a joint effort by prostate cancer researchers and experts from around the country and will seek to find out why African…

Music Helps Ease Pain and Fatigue of Breast Cancer, Study Shows

Music Helps Ease Pain and Fatigue of Breast Cancer, Study Shows

This post was originally published on this site Listening to music at home can considerably ease the severity of symptoms related to breast cancer and its treatments, helping reduce the pain and fatigue patients experience, a trial reports. It found that setting time aside nearly every day for music significantly lessened patients’ intensity of pain and…